MarketInOut Stock Screener Log In | Sign Up
 

Sanofi S.A.

MIL • Healthcare • Drug Manufacturers - General • Quote as of 05/08/2026
Sanofi S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization95,954 mln
Float1,091 mln
Earnings Date04/23/2026

EPS

3.96
Solid

P / E

18.45
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.45
Borderline

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.28
Very low leverage

Business Description

Sanofi is a Paris-based global pharmaceutical company founded in 1994 that discovers, develops, and sells medicines and vaccines across a wide range of health conditions, including rare diseases, cancer, neurological disorders, and immune system conditions. The company partners with numerous biotechnology and AI-driven firms to advance new treatment approaches, including protein therapies, genome editing, and antibody-based medicines. Its vaccine portfolio covers many serious infectious diseases, from polio and hepatitis to rabies and yellow fever.

Key Fundamentals

EPS3.96
P/E18.45
ROE10.71
RPS38.04
ROIC7.04
ROA6.09
Interest Cover15.33
EBITDA, mln12,479
EV / EBITDA8.87
EV / EBIT16.28
Revenue, mln46,716
EV / Revenue2.37

Financial Strength

Altman Z-Score1.61
Piotroski F-Score 7 / 9
Beneish M-Score-2.45
Price to Intrinsic Value0.79
Price to Graham Number3.80
Shiller PE Ratio13.84

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.63% 20 / 100   
1 Month -4.17% 21 / 100   
2 Months 0.08% 49 / 100   
6 Months -11.7% 32 / 100   
1 Year -12.49% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us